Anheuser-Busch InBev SA/NV ADR (NYSE: BUD)’s stock price has increased by 1.59 compared to its previous closing price of 70.66. However, the company has seen a 2.88% increase in its stock price over the last five trading sessions. https://247wallst.com reported 2025-06-03 that Shares of Altria Group Inc. (NYSE: MO) gained 1.27% over the past month but have risen 7.63% since May 14. So far this year, the stock is up 15.46% while also paying a sizable dividend that currently yields 6.73%. So far in 2025, the Dividend King is not only outpacing its benchmark index but continuing to reward income investors as it has now increased its distribution 59 times over the past 55 years. When the company reported Q1 earnings in April, it missed on revenue by -2.09% but beat on EPS by 3.52%. That miss on revenue is unlikely to impact forward guidance, however, as the stock’s sizable payout ratio continues to attract investors amid a landscape of uncertainty. Over the past six months, MO has gained 10.21% and is up 34.88% over the past year, outperforming the S&P 500 over the same period by an eye-catching 22.75%. Among iconic American brands, Altria’s Marlboro cigarettes are as recognizable as iPhones, Levi Jeans and Coca-Cola. While the company’s origins can be traced back to George Weyman’s tobacco shop in 1822, Altria filed its first annual report as Philip Morris in 1920 and would come to dominate U.S. tobacco throughout the 20th century and beyond. As Philip Morris branched out to acquire General Foods and Kraft, among others, it changed its name in 2003 to Altria Group while retaining the “MO” ticker. Altria has continued to grow at an albeit slower pace, due to health risks associated with tobacco use that has caused legislative restrictions. However, as a Dividend King and an institutional investment favorite, the company remains historically reliable and, as evidenced by its performance so far in 2025, more than capable of weathering severe market downturns. Key Points In This Article: Altria purchase of vape maker NJOY gives it access to a massive distribution network. Marlboro remains a giant in the U.S. cigarette industry with 42% of the market share. If you’re looking for a megatrend with massive potential, make sure to grab a complimentary copy of our “The Next NVIDIA” report. This report breaks down AI stocks with 10x potential and will give you a huge leg up on profiting from this massive sea change. Altria’s Recent Stock Success In 2016, Altria acquired 10% of Anheuser Busch InBev NV ADR (NYSE: BUD), the maker of Budweiser beer. The company has since reduced its stake to 8%, but the initial investment marked a run of M&A activity that increased CapEx but intrinsically increased the company’s valuation. Sherman Group Holdings, LLC was purchased in 2018, followed by Helix Innovations and Cronos Group — a medical and recreational cannabis company — being added to the Altria portfolio in 2019. In 2023, the company acquired NJOY. Fiscal Year Price Revenues Net Income 2015 $58.21 $18.854 B $5.241 B 2016 $67.62 $19.337 B $14.239 B 2017 $71.41 $19.494 B $10.222 B 2018 $49.39 $19.627 B $6.963 B 2019 $49.91 $19.796 B (-$1.239 B) 2020 $41.00 $20.841 B $4.467 B 2021 $47.39 $21.111 B $2.475 B 2022 $45.71 $20.688 B $5.764 B 2023 $40.34 $20.502 B $8.130 B 2024 $52.38 $24.018 B $11.236 B From FY 2020 to FY 2024, Altria returned more than $32 billion to shareholders in the form of dividends. Over the same period, it was able to repurchase $7.9 billion worth of stock. And from August 2023 to August 2024, the company increased its dividend by more than 4.1%. Key Drivers for Altria’s Stock in the Future 1. Growing Demand for Smokeless Products: Globally, the smokeless product industry is valued at $16.81 billion and is projected to undergo a compound annual growth rate (CAGR) of 4.8% from 2024 to 2030. While 84.9% of distribution is offline, online distribution is forecast for a 6.2% CAGR through 2030, which is likely to help bolster sales as these products continue to expand their global reach. NJOY achieved the first-ever FDA marketing granted orders for menthol e-vapor products. 2. Continuous Dividend Growth: Last year, Altria notched its 55th consecutive year of dividend growth. The stock continues to be a favorite among income investors, and it currently pays a dividend yielding 6.87%. For context, yield-investing fan favorite Schwab U.S. Dividend Equity ETF (NYSE: SCHD) currently only pays 4.04% and has seen a year-to-date loss of 4.81%. As such, Altria continues to provide investors with a safe haven, alluring (and sustainable) yield and impressive share performance. 3. Emerging Markets: Cronos (cannabinoid) and Helix (oral nicotine pouches) were both acquired in 2019 and should help Altria expand into those respective markets. This is particularly relevant in light of the FDA announcing in January 2025 that it has authorized marketing of 20 ZYN Nicotine Pouch Products — a major competitor — following an extensive scientific review. Altria (MO) Price Prediction for 2025 According to Wall Street analysts, the current consensus one-year price target for Altria Group is $56.86, which represents potential downside of 6.21% over the next 12 months based on the current share price. Of the eights analysts covering MO, the stock is given a consensus “Hold” rating, with three assigning a “Buy” rating, three assigning a “Hold” rating and two assigning a “Sell” rating. On the other hand, 24/7 Wall St.‘s forecast is close, with a projected price target for Altria Group of $57.27, or 5.54% potential downside from the stock’s current price. We believe that Altria’s high dividend and relatively low P/E ratio will continue to attract investors, which will in turn support the stock price amid the ongoing downturn in the broad market. Altria Stock Price Target 2025–2030 By the conclusion of 2030, 24/7 Wall St. estimates that Altria’s stock will be trading for $65.15, good for an 7.45% increase over today’s share price, based on an EPS of $6.05. Year EPS Price Target %Change From Current Price 2025 $5.32 $57.27 -5.54% 2026 $5.50 $59.24 -2.29% 2027 $5.67 $61.06 0.70% 2028 $5.77 $62.10 2.42% 2029 $5.90 $63.55 4.81% 2030 $6.05 $65.15 7.45% The post Altria Group, Inc. (NYSE: MO) Price Prediction and Forecast 2025-2030 (June 2025) appeared first on 24/7 Wall St..
Is It Worth Investing in Anheuser-Busch InBev SA/NV ADR (NYSE: BUD) Right Now?
Anheuser-Busch InBev SA/NV ADR (NYSE: BUD) has a price-to-earnings ratio that is above its average at 25.07x. The stock has a 36-month beta value of 0.84. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 5 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for BUD is 1.75B, and at present, short sellers hold a 0.35% of that float. On June 04, 2025, the average trading volume of BUD was 2.37M shares.
BUD’s Market Performance
The stock of Anheuser-Busch InBev SA/NV ADR (BUD) has seen a 2.88% increase in the past week, with a 8.79% rise in the past month, and a 15.35% gain in the past quarter. The volatility ratio for the week is 0.95%, and the volatility levels for the past 30 days are at 1.07% for BUD. The simple moving average for the past 20 days is 4.69% for BUD’s stock, with a 20.60% simple moving average for the past 200 days.
Analysts’ Opinion of BUD
Many brokerage firms have already submitted their reports for BUD stocks, with Goldman repeating the rating for BUD by listing it as a “Buy.” The predicted price for BUD in the upcoming period, according to Goldman is $88 based on the research report published on May 12, 2025 of the current year 2025.
Argus gave a rating of “Buy” to BUD, setting the target price at $70 in the report published on March 27th of the current year.
BUD Trading at 9.56% from the 50-Day Moving Average
After a stumble in the market that brought BUD to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 0.69% of gains for the given period.
#####
#####
Stock Fundamentals for BUD
Current profitability levels for the company are sitting at:
- 0.26 for the present operating margin
- 0.56 for the gross margin
The net margin for Anheuser-Busch InBev SA/NV ADR stands at 0.12. The total capital return value is set at 0.09. Equity return is now at value 7.31, with 2.72 for asset returns.
The debt to equity ratio resting at 0.92. The interest coverage ratio of the stock is 3.73.
Currently, EBITDA for the company is 20.25 billion with net debt to EBITDA at 3.85. When we switch over and look at the enterprise to sales, we see a ratio of 3.45. The receivables turnover for the company is 10.69for trailing twelve months and the total asset turnover is 0.28. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.70.
Conclusion
To sum up, Anheuser-Busch InBev SA/NV ADR (BUD) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
